Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

Published:2020-04 Issue:4 Volume:77 Page:403-417
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Perera Marlon,Papa Nathan,Roberts Matthew,Williams Michael,Udovicich Cristian,Vela Ian,Christidis Daniel,Bolton Damien,Hofman Michael S.,Lawrentschuk Nathan,Murphy Declan G.

Funder

Royal Australasian College of Surgeons Scholarship

Prostate Cancer Foundation of Australia's Research Program

Publisher

Elsevier BV

Subject

Urology

Reference67 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature;Ost;Eur Urol,2015

3. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018

4. Stereotactic ablative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial;Siva;Eur Urol,2018

5. Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review;Ploussard;Eur Urol,2019

Cited by 688 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale;Clinical Genitourinary Cancer;2024-12

2. Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer;Clinical and Translational Oncology;2024-09-12

3. Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse;Abdominal Radiology;2024-09-10

4. The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers;Current Oncology;2024-09-08

5. Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-02